Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology
Notice NOT-CA-23-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2023 Category: Research Source Type: funding
Notice of Request for Proposals (RFP), Solicitation 75N91023R00024: PREVENT Cancer Preclinical Drug Development Program
Notice NOT-CA-23-034 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 9, 2023 Category: Research Source Type: funding
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-088 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may support the acquisition of we...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 6, 2023 Category: Research Source Type: funding
Dear Colleague Letter: MPS-NCI SuPporting new AReas of Knowledge (SPARK): Cancer as a Living Material - New Ideas and New Connection
Available Formats: HTML: https://www.nsf.gov/pubs/2023/nsf23039/nsf23039.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2023/nsf23039/nsf23039.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf23039This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - January 4, 2023 Category: Science Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplement to Support Global Cancer Stigma Research
Notice NOT-CA-23-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 29, 2022 Category: Research Source Type: funding
Notice of Change to PAR-22-114, Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Notice NOT-CA-23-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 27, 2022 Category: Research Source Type: funding
Notice of Proposed Contract Action (Presolicitation) for Request for Proposals (RFP) Solicitation 75N91023R00024: PREVENT Cancer Preclinical Drug Development Program
Notice NOT-CA-23-028 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 27, 2022 Category: Research Source Type: funding
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-075 from the NIH Guide for Grants and Contracts. The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects. Kids First has established and continues to develop a Data Resource including a collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central port...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 23, 2022 Category: Research Source Type: funding
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-014 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Researc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2022 Category: Research Source Type: funding
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-015 from the NIH Guide for Grants and Contracts. The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT....
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2022 Category: Research Source Type: funding
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2022 Category: Research Source Type: funding
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Techno...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2022 Category: Research Source Type: funding
Notice to Extend the Response Date for NOT-CA-23-007, "Request for Information (RFI): Soliciting Input on the Use and Reuse of Cancer Metabolomics Data"
Notice NOT-CA-23-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2022 Category: Research Source Type: funding
Notice of Change to Application Due Dates for PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Notice NOT-CA-23-024 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2022 Category: Research Source Type: funding
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
Funding Opportunity PAR-23-059 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2022 Category: Research Source Type: funding
